These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6970038)

  • 1. Suppression of T-cell mediated lymphokine production but not cytotoxic activity by macrophages.
    Varesio L; Eva A; Cavallo G; Herberman RB
    Boll Ist Sieroter Milan; 1980 Mar; 59(1):12-6. PubMed ID: 6970038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of lymphocyte activation: macrophage-dependent suppression of T lymphocyte protein synthesis.
    Varesio L; Holden HT
    J Immunol; 1980 Oct; 125(4):1694-701. PubMed ID: 6997385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of B cell MIF production by T cells and soluble T cell-derived factors.
    Cohen S; Yoshida T
    J Immunol; 1977 Aug; 119(2):719-21. PubMed ID: 328780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of macrophages in the production of lymphokines by T and B lymphocytes.
    Wahl SM; Wilton JM; Rosenstreich DL; Oppenheim JJ
    J Immunol; 1975 Apr; 114(4):1296-301. PubMed ID: 1090672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
    Pels E; De Weger RA; Den Otter W
    Int Arch Allergy Appl Immunol; 1984; 74(2):140-6. PubMed ID: 6609130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the mixed leukocyte culture reaction by suppressor cells.
    Rode HN; Uotila M; Gordon J
    Eur J Immunol; 1978 Mar; 8(3):213-6. PubMed ID: 149009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.
    Schleifer KW; Mansfield JM
    J Immunol; 1993 Nov; 151(10):5492-503. PubMed ID: 8228241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 in cell-mediated immune responses.
    Paetkau V; Shaw J; Caplan B; Mills GB; Lee KC
    J Supramol Struct; 1980; 13(2):271-80. PubMed ID: 6972471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible lymphokines of T cell tumors.
    Corley RB; Dexter CM; Ovnic M
    Crit Rev Immunol; 1986; 6(1):71-103. PubMed ID: 3522104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
    Robinson MK; Truitt GA; Okayasu T; Wheelock EF
    Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tumour carriage on the production of lymphokines affecting macrophage behaviour.
    McIntosh LC; Morrice LM; Udagawa Y; Thomson AW
    Immunology; 1986 Mar; 57(3):359-65. PubMed ID: 3485563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.
    Yoshida T; Kuratsuji T; Takada A; Takada Y; Minowada J; Cohen S
    J Immunol; 1976 Aug; 117(2):548-54. PubMed ID: 781133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.